ebomi
Colour theme
Sign in
Insider · CIK 0001900772

Burns James William

CIK 0001900772 Name as filed on the most recent filing

Filed as Burns James William (12)

19 transaction lines · from 12 filings · filed 2023-06-30 to 2026-04-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

19 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-04-02 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 3,280 disposed 34.71 113,848.80 Form 4, filing 0001439222-26-000067
2026-03-02 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,681 disposed 28.96 48,681.76 Form 4, filing 0001439222-26-000042
2026-03-02 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,187 disposed 28.96 34,375.52 Form 4, filing 0001439222-26-000042
2026-03-02 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,187 disposed 28.96 34,375.52 Form 4, filing 0001439222-26-000042
2026-03-02 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,163 disposed 28.96 33,680.48 Form 4, filing 0001439222-26-000042
2025-12-30 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 2,932 disposed 27.09 79,427.88 Form 4, filing 0001439222-26-000010
2025-06-24 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 2,799 disposed 33.54 93,878.46 Form 4, filing 0001439222-25-000071
2025-03-03 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,681 disposed 35.54 59,742.74 Form 4, filing 0001439222-25-000021
2025-03-03 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,187 disposed 35.54 42,185.98 Form 4, filing 0001439222-25-000021
2025-03-03 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,137 disposed 35.54 40,408.98 Form 4, filing 0001439222-25-000021
2024-11-07 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 13,411 disposed 52.00 697,372.00 Form 4, filing 0001439222-24-000140
2024-11-07 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 8,341 disposed 52.56 438,402.96 Form 4, filing 0001439222-24-000140
2024-03-05 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,349 disposed 32.57 43,936.93 Form 4, filing 0001439222-24-000046
2024-03-05 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,293 disposed 32.57 42,113.01 Form 4, filing 0001439222-24-000046
2024-02-14 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 545 disposed 25.14 13,701.30 Form 4, filing 0001439222-24-000028
2024-01-24 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,708 disposed 21.64 36,961.12 Form 4, filing 0001439222-24-000022
2024-01-09 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,163 disposed 22.99 26,737.37 Form 4, filing 0001439222-24-000006
2023-08-17 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 6,395 disposed 26.28 168,060.60 Form 4, filing 0001439222-23-000131
2023-06-30 Agios Pharmaceuticals, Inc.
AGIO 		S, Open-market sale 1,707 disposed 28.36 48,410.52 Form 4, filing 0001439222-23-000109

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 19
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Burns James William, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001900772

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.